PAYDAS, S. Et Al. 2023. Prognostic Significance of Combined Inflammatory Index (CII) in Nodular Lymphocyte Predominant Hodgkin Lymphoma. Eurasian Journal of Medical Investigation , vol.7, no.3 , 235-245.

PAYDAS, S., CAKAR, M. K., BARISTA, I., SEYDAOGLU, G., PEHLIVAN, M., DOGAN, M., ... ALTUNTAS, F.(2023). Prognostic Significance of Combined Inflammatory Index (CII) in Nodular Lymphocyte Predominant Hodgkin Lymphoma. Eurasian Journal of Medical Investigation , vol.7, no.3, 235-245.

PAYDAS, Semra Et Al. "Prognostic Significance of Combined Inflammatory Index (CII) in Nodular Lymphocyte Predominant Hodgkin Lymphoma," Eurasian Journal of Medical Investigation , vol.7, no.3, 235-245, 2023

PAYDAS, Semra Et Al. "Prognostic Significance of Combined Inflammatory Index (CII) in Nodular Lymphocyte Predominant Hodgkin Lymphoma." Eurasian Journal of Medical Investigation , vol.7, no.3, pp.235-245, 2023

PAYDAS, S. Et Al. (2023) . "Prognostic Significance of Combined Inflammatory Index (CII) in Nodular Lymphocyte Predominant Hodgkin Lymphoma." Eurasian Journal of Medical Investigation , vol.7, no.3, pp.235-245.

@article{article, author={Semra PAYDAS Et Al. }, title={Prognostic Significance of Combined Inflammatory Index (CII) in Nodular Lymphocyte Predominant Hodgkin Lymphoma}, journal={Eurasian Journal of Medical Investigation}, year=2023, pages={235-245} }